SEC Form 4 · accession 0001578563-18-000009
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Uli Hacksell
Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 7:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.71 | May 15, 2018 | A | 8,357 | A | May 15, 2019 | May 14, 2028 | Common Stock | 8,357 | 8,357 | D |
Explanation of responses
- F1The stock options will vest in full on May 15, 2019, subject to the grantee's continued service on such vesting date.